WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $12.61, but opened at $13.3399. WuXi Biologics (Cayman) shares last traded at $13.3399, with a volume of 1,041 shares changing hands.
Analyst Ratings Changes
Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.
Check Out Our Latest Stock Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Trading Down 1.8%
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
- Braze Beat Expectations—Now 2 SaaS Peers Are in Focus
- 3 Zero-Fee ETFs Worth More Than Their Cost
- 3 Nimble Free Cash Flow Names With Light Assets
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
